12:00 AM
 | 
Jul 29, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Amgen Inc.

(AMGN), Thousand Oaks, Calif.

Business: Biopharmaceuticals

Morgan Stanley analyst Caroline Copithorne raised her rating to "overweight" from "equal weight" and increased her 2002 and 2003 EPS estimates to $1.46 and $1.77 from $1.38 and $1.73, respectively. Last week, AMGN posted second quarter...

Read the full 220 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >